KITLG | KIT ligand | Cancer-related genes Cytoskeleton related proteins Disease related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Mixed |
KRAS | Kirsten rat sarcoma viral oncogene homolog | Cancer-related genes Disease related genes Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
KSR1 | Kinase suppressor of ras 1 | Enzymes Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
KSR2 | Kinase suppressor of ras 2 | Enzymes Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Tissue enhanced |
LAT | Linker for activation of T cells | Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
MAP2K1 | Mitogen-activated protein kinase kinase 1 | Cancer-related genes Cytoskeleton related proteins Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
MAP2K2 | Mitogen-activated protein kinase kinase 2 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
MAPK1 | Mitogen-activated protein kinase 1 | Cancer-related genes Cytoskeleton related proteins Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
MAPK10 | Mitogen-activated protein kinase 10 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Tissue enhanced |
MAPK3 | Mitogen-activated protein kinase 3 | Cancer-related genes Cytoskeleton related proteins Enzymes FDA approved drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
MAPK8 | Mitogen-activated protein kinase 8 | Cancer-related genes Enzymes Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
MAPK9 | Mitogen-activated protein kinase 9 | Enzymes Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
MET | MET proto-oncogene, receptor tyrosine kinase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Expressed in all |
MLLT4 | Myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
MRAS | Muscle RAS oncogene homolog | Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
NF1 | Neurofibromin 1 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
NFKB1 | Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | Cancer-related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins RAS pathway related proteins Transcription factors
| | | | | Expressed in all |
NGF | Nerve growth factor (beta polypeptide) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
NGFR | Nerve growth factor receptor | Cancer-related genes CD markers Predicted intracellular proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Mixed |
NRAS | Neuroblastoma RAS viral (v-ras) oncogene homolog | Cancer-related genes Disease related genes Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
PAK1 | P21 protein (Cdc42/Rac)-activated kinase 1 | Enzymes Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
PAK2 | P21 protein (Cdc42/Rac)-activated kinase 2 | Enzymes Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
PAK3 | P21 protein (Cdc42/Rac)-activated kinase 3 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Tissue enhanced |
PAK4 | P21 protein (Cdc42/Rac)-activated kinase 4 | Enzymes Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
PAK6 | P21 protein (Cdc42/Rac)-activated kinase 6 | Enzymes Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Tissue enhanced |
PAK6 | P21 protein (Cdc42/Rac)-activated kinase 6 | Predicted intracellular proteins RAS pathway related proteins
| | | | | Tissue enhanced |
PAK7 | P21 protein (Cdc42/Rac)-activated kinase 7 | Enzymes Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Tissue enhanced |
PDGFA | Platelet-derived growth factor alpha polypeptide | Cancer-related genes Candidate cardiovascular disease genes Predicted intracellular proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Expressed in all |
PDGFB | Platelet-derived growth factor beta polypeptide | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
PDGFC | Platelet derived growth factor C | Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
PDGFD | Platelet derived growth factor D | Predicted intracellular proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Expressed in all |
PDGFRA | Platelet-derived growth factor receptor, alpha polypeptide | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
PDGFRB | Platelet-derived growth factor receptor, beta polypeptide | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
PGF | Placental growth factor | Cancer-related genes Candidate cardiovascular disease genes FDA approved drug targets Plasma proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
PIK3CA | Phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
PIK3CB | Phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
PIK3CD | Phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Mixed |
PIK3CG | Phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma | Cancer-related genes Enzymes Predicted intracellular proteins RAS pathway related proteins
| | | | | Tissue enhanced |
PIK3R1 | Phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
PIK3R2 | Phosphoinositide-3-kinase, regulatory subunit 2 (beta) | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
PIK3R3 | Phosphoinositide-3-kinase, regulatory subunit 3 (gamma) | Cancer-related genes Predicted intracellular proteins RAS pathway related proteins
| | | | | Mixed |
PIK3R5 | Phosphoinositide-3-kinase, regulatory subunit 5 | Disease related genes Predicted intracellular proteins RAS pathway related proteins
| | | | | Tissue enhanced |
PLA1A | Phospholipase A1 member A | Predicted intracellular proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
PLA2G10 | Phospholipase A2, group X | Enzymes Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
PLA2G12A | Phospholipase A2, group XIIA | Enzymes Predicted secreted proteins RAS pathway related proteins
| | | | | Expressed in all |
PLA2G12B | Phospholipase A2, group XIIB | Plasma proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Group enriched |
PLA2G16 | Phospholipase A2, group XVI | Enzymes Predicted intracellular proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Expressed in all |
PLA2G1B | Phospholipase A2, group IB (pancreas) | Candidate cardiovascular disease genes Enzymes FDA approved drug targets Predicted intracellular proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
PLA2G2A | Phospholipase A2, group IIA (platelets, synovial fluid) | Enzymes FDA approved drug targets Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
PLA2G2C | Phospholipase A2, group IIC | Predicted secreted proteins RAS pathway related proteins
| | | | | Not detected |